Human CA2/CA-II/CAC ORF/cDNA clone-Lentivirus plasmid (NM_000067)
Cat. No.: pGMLP002928
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human CA2/CA-II/CAC Lentiviral expression plasmid for CA2 lentivirus packaging, CA2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
CA2/CA-II/CA2/CA-II products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLP002928 |
| Gene Name | CA2 |
| Accession Number | NM_000067 |
| Gene ID | 760 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 783 bp |
| Gene Alias | CA-II,CAC,CAII,Car2,HEL-76,HEL-S-282 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGTCCCATCACTGGGGGTACGGCAAACACAACGGACCTGAGCACTGGCATAAGGACTTCCCCATTGCCAAGGGAGAGCGCCAGTCCCCTGTTGACATCGACACTCATACAGCCAAGTATGACCCTTCCCTGAAGCCCCTGTCTGTTTCCTATGATCAAGCAACTTCCCTGAGGATCCTCAACAATGGTCATGCTTTCAACGTGGAGTTTGATGACTCTCAGGACAAAGCAGTGCTCAAGGGAGGACCCCTGGATGGCACTTACAGATTGATTCAGTTTCACTTTCACTGGGGTTCACTTGATGGACAAGGTTCAGAGCATACTGTGGATAAAAAGAAATATGCTGCAGAACTTCACTTGGTTCACTGGAACACCAAATATGGGGATTTTGGGAAAGCTGTGCAGCAACCTGATGGACTGGCCGTTCTAGGTATTTTTTTGAAGGTTGGCAGCGCTAAACCGGGCCTTCAGAAAGTTGTTGATGTGCTGGATTCCATTAAAACAAAGGGCAAGAGTGCTGACTTCACTAACTTCGATCCTCGTGGCCTCCTTCCTGAATCCTTGGATTACTGGACCTACCCAGGCTCACTGACCACCCCTCCTCTTCTGGAATGTGTGACCTGGATTGTGCTCAAGGAACCCATCAGCGTCAGCAGCGAGCAGGTGTTGAAATTCCGTAAACTTAACTTCAATGGGGAGGGTGAACCCGAAGAACTGATGGTGGACAACTGGCGCCCAGCTCAGCCACTGAAGAACAGGCAAATCAAAGCTTCCTTCAAATAA |
| ORF Protein Sequence | MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T20401-Ab | Anti-CA-II monoclonal antibody |
| Target Antigen | GM-Tg-g-T20401-Ag | CA-II/CA2 protein |
| ORF Viral Vector | pGMLP002928 | Human CA2 Lentivirus plasmid |
| ORF Viral Vector | vGMLP002928 | Human CA2 Lentivirus particle |
Target information
| Target ID | GM-T20401 |
| Target Name | CA2/CA-II |
|
Gene Group Identifier (Target Gene ID in Homo species) |
760 |
| Gene ID |
100050059 (Equus caballus), 101094903 (Felis catus), 12349 (Mus musculus), 477928 (Canis lupus familiaris) 54231 (Rattus norvegicus), 574263 (Macaca mulatta), 760 (Homo sapiens) |
| Gene Symbols & Synonyms | CA2,Car2,Ca2,CAII,Car-2,Ltw-5,Lvtw-5,CAC,CA-II,HEL-76,HEL-S-282 |
| Target Alternative Names | CA-II,CA2,CAC,CAII,Ca2,Car-2,Car2,Carbonate dehydratase II,Carbonic anhydrase 2,Carbonic anhydrase C (CAC),Carbonic anhydrase II (CA-II),Cyanamide hydratase CA2,HEL-76,HEL-S-282,Ltw-5,Lvtw-5 |
| Uniprot Accession |
P00918,P00920,P27139
Additional SwissProt Accessions: P00920,P27139,P00918 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target |
| Disease | |
| Disease from KEGG | Metabolic pathways, Gastric acid secretion, Pancreatic secretion, Bile secretion |
| Gene Ensembl | ENSECAG00000016228, ENSMUSG00000027562, ENSCAFG00845017325, ENSMMUG00000014891, ENSG00000104267 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


